To understand the effect of oncogenic alterations on the tumorigenic potential of bronchial epithelial cells, we previously generated a panel of immortalized HBECs harboring either K-rasV12 expression, p53 knockdown, or both changes, which are major mutations in lung cancer [32, 33]. This evidence concerns the gene TP53 and lung carcinoma.